As of 2026-02-13, the Intrinsic Value of Vaxcyte Inc (PCVX) is -25.10 USD. This PCVX valuation is based on the model Peter Lynch Fair Value. With the current market price of 55.35 USD, the upside of Vaxcyte Inc is -145.35%.
Based on its market price of 55.35 USD and our intrinsic valuation, Vaxcyte Inc (PCVX) is overvalued by 145.35%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -25.10 - -25.10 | -25.10 | -145.35% |
| P/E | (60.95) - (102.21) | (86.85) | -256.9% |
| DDM - Stable | (41.72) - (143.97) | (92.85) | -267.7% |
| DDM - Multi | (4.16) - (11.17) | (6.06) | -111.0% |
| Market Cap (mil) | 7,245.87 |
| Beta | 2.35 |
| Outstanding shares (mil) | 130.91 |
| Enterprise Value (mil) | 6,964.79 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.78% |
| Cost of Debt | 5.00% |
| WACC | 6.73% |